在移除导致高血症的颗粒瘤后,临床改善
Rubén Abdala1, Osvaldo D Messina2,3, Carolina Habib4
1IDIM, Instituto de Diagnóstico e Investigaciones Metabólicas, Cátedra de Osteología y Metabolismo Mineral, Facultad de Medicina, Universidad del Salvador, Buenos Aires, Argentina.
Medicina
|August 22, 2024
概括
一名妇女因异常维生素D生产而患上高血症,与脏填充剂有关. 手术切除颗粒瘤导致了3年的临床稳定性,突出了审美手术的罕见并发症.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 皮肤病学 皮肤病学
背景情况:
- 宫外产生的1,25(OH) 2D可以导致高血症.
- 颗粒瘤形成是美学质填充剂的已知并发症.
- 源不明的高血症需要进行彻底的调查.
研究的目的:
- 为了呈现一种独特的超血病病例,该病例归因于子宫外的1,25(OH) 2D生产.
- 为了突出审美手术的潜在内分泌并发症.
- 讨论这些案件的管理和结果.
主要方法:
- 案例报告的呈现方式.
- 对高血症的临床评估.
- 检查患者病史,包括整形外科手术.
- 评估颗粒瘤的形成和治疗.
主要成果:
- 患者出现了临床高血症.
- 宫外1,25(OH) 2D的产生被确定为原因.
- 脏填充剂和随后的颗粒瘤都与此有关.
- 手术切除颗粒瘤导致持续临床稳定3年.
结论:
- 审美性质填充剂可能导致颗粒瘤,可能导致异卵巢1,25(OH) 2D产生和高血症.
- 对这些颗粒瘤进行手术可以是一个有效的管理策略.
- 这一案例强调了考虑高血症的阴性原因的重要性.
相关概念视频
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K


